Hypoxia Inducible Factor (HIF) Hydroxylases as Regulators of Intestinal Epithelial Barrier Function

Autor: Mario C. Manresa, Cormac T. Taylor
Rok vydání: 2017
Předmět:
0301 basic medicine
Epithelial Barrier
Cell
NF-κB
nuclear factor-κB

Review
Disease
Biology
Inflammatory bowel disease
Hypoxia-Inducible Factor (HIF) Hydroxylases
FIH
factor inhibiting hypoxia-inducible factor

03 medical and health sciences
chemistry.chemical_compound
0302 clinical medicine
ZO
zonula occludens

CD
Crohn’s disease

medicine
DSS
dextran sodium sulfate

lcsh:RC799-869
Hypoxia
TNF-α
tumor necrosis factor α

Barrier function
Lung
DMOG
dimethyloxalylglycine

IBD
inflammatory bowel disease

Hepatology
Inflammatory Bowel Disease
Gastroenterology
NF-κB
Hypoxia (medical)
medicine.disease
IL
interleukin

3. Good health
Cell biology
HIF
hypoxia-inducible factor

UC
ulcerative colitis

TJ
tight junction

030104 developmental biology
medicine.anatomical_structure
chemistry
Hypoxia-inducible factors
TFF
trefoil factor

030220 oncology & carcinogenesis
Immunology
PHD
hypoxia-inducible factor–prolyl hydroxylases

lcsh:Diseases of the digestive system. Gastroenterology
medicine.symptom
TLR
Toll-like receptor
Zdroj: Cellular and Molecular Gastroenterology and Hepatology, Vol 3, Iss 3, Pp 303-315 (2017)
Cellular and Molecular Gastroenterology and Hepatology
ISSN: 2352-345X
DOI: 10.1016/j.jcmgh.2017.02.004
Popis: Human health is dependent on the ability of the body to extract nutrients, fluids, and oxygen from the external environment while at the same time maintaining a state of internal sterility. Therefore, the cell layers that cover the surface areas of the body such as the lung, skin, and gastrointestinal mucosa provide vital semipermeable barriers that allow the transport of essential nutrients, fluid, and waste products, while at the same time keeping the internal compartments free of microbial organisms. These epithelial surfaces are highly specialized and differ in their anatomic structure depending on their location to provide appropriate and effective site-specific barrier function. Given this important role, it is not surprising that significant disease often is associated with alterations in epithelial barrier function. Examples of such diseases include inflammatory bowel disease, chronic obstructive pulmonary disease, and atopic dermatitis. These chronic inflammatory disorders often are characterized by diminished tissue oxygen levels (hypoxia). Hypoxia triggers an adaptive transcriptional response governed by hypoxia-inducible factors (HIFs), which are repressed by a family of oxygen-sensing HIF hydroxylases. Here, we review recent evidence suggesting that pharmacologic hydroxylase inhibition may be of therapeutic benefit in inflammatory bowel disease through the promotion of intestinal epithelial barrier function through both HIF-dependent and HIF-independent mechanisms. Keywords: Epithelial Barrier, Inflammatory Bowel Disease, Hypoxia, Hypoxia-Inducible Factor (HIF) Hydroxylases
Databáze: OpenAIRE